Hikma Ventures is a $100M evergreen corporate VC fund that serves as the strategic venture arm of Hikma Pharmaceuticals, with an explicit mandate to create two-way strategic value between portfolio companies and Hikma's existing value chain in areas like respiratory, CNS, oncology, and chronic diseases. The fund focuses globally on digital health and life sciences that enhance a large pharma's generic and branded generics business model, while leveraging Hikma's MENA region roots to act as a regional bridge for startups seeking access to Middle Eastern markets.